Results 101 to 110 of about 5,052,436 (221)
An integrated trust and reputation model for open multi-agent systems [PDF]
Trust and reputation are central to effective interactions in open multi-agent systems in which agents, that are owned by a variety of stakeholders, continuously enter and leave the system.
Huynh, TD +5 more
core +1 more source
ABSTRACT Background Evidence regarding the risk‐stratified effectiveness of drug‐coated balloon (DCB)‐based PCI for de novo coronary artery disease (CAD) remains limited, particularly in patients undergoing complex and high‐risk indicated percutaneous coronary intervention (CHIP PCI).
Dong Oh Kang +3 more
wiley +1 more source
Dissecting intramural hematoma of esophagus after thrombolytic therapy: A case report
Esophageal hematoma is a relatively rare event. We report a case of severe chest pain associated with myocardial infarction and recurrent chest pain after administration of a thrombolytic agent.
Chehrehgosha, H. +5 more
core
ICU 28‐day all‐cause mortality was 6.1% (410/6769). During the first 5 days, platelet counts were significantly lower in ICU 28‐day non‐survivors than in survivors. The difference in platelet counts between ICU 28‐day non‐survivors and survivors increased by an average of 15.4 × 109/L daily (95% CI, 14.1 to 16.7).
Tianlai Lin +6 more
wiley +1 more source
Mice received bilateral hippocampal injections of an AAV vector expressing NL2, followed by repeated PTZ administration. NL2 expression in the HPC attenuated seizure progression and reduced c‐Fos expression in the ventral HPC. These findings suggest that AAV‐mediated NL2 expression in the HPC may be a potential therapeutic strategy for seizure control.
Tomohiro Tokutake +12 more
wiley +1 more source
In-vitro thrombolytic activity of Allium cepa L. group Aggregatum (Shallot) ethanolic extract
Thrombosis refers to the formation of a blood clot within a blood vessel. It is associated with conditions such as myocardial infarction, ischemic stroke, and deep vein thrombosis that may be affected by obesity, age, cholesterol levels, and similar risk
Silao, Jade Nicole D. +4 more
core
In vitro thrombolytic potential of bioactive compounds from marine Streptomyces sp. VITJS4
The most practical approach to reduce morbidity and mortality of coronary heart disease (CHD) is to delay the process of thrombus by usage of clot-dissolving agents. The necessities of such safer compounds are to be critically examined for thrombolyticÂ
S Jemimah Naine +2 more
doaj +1 more source
ABSTRACT This study tested whether combined dapagliflozin (DAPA) and melatonin (Mel) therapy was superior to merely one for ameliorating the left ventricular (LV) fibrosis/remodeling and improving LV ejection fraction (LVEF) in rats after acute myocardial infarction (AMI). In vitro study demonstrated that DAPA treatment significantly suppressed the TGF‐
Jiunn‐Jye Sheu +6 more
wiley +1 more source
Labeling of the Recombinant Streptokinase Using Iodine-131 as a New Thrombolytic Agent
Stroke and acute myocardial infarction is a disease with the highest mortality in the world. WHO has estimated in 2008, 30% of deaths from heart disease and more than 80% of this cases have been occurred in developing countries.
I. Daruwati +3 more
doaj
Biosurfactant‐producing bacteria were isolated from hydrocarbon‐contaminated industrial effluent in Dhaka, Bangladesh, using selective diesel liquid enrichment. Functional screening confirmed surfactant activity via oil displacement, drop‐collapse, and emulsification index assays.
Ummey Fatema Tun Amina +3 more
wiley +1 more source

